Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Jacob

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Therapeutic Advances in Neurological Disorders|March 6, 2023
Microglia as a cellular target of diclofenac therapy in Alzheimer's diseaseBarbara E Stopschinski, Rick A Weideman, Danni McMahan, et al.
JACC. Advances|January 6, 2025
Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk ScoreSubhash Banerjee, Rick A Weideman, David A Jacob, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2020
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United StatesNicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Therapeutic Advances in Neurological Disorders|March 6, 2023
Microglia as a cellular target of diclofenac therapy in Alzheimer's diseaseBarbara E Stopschinski, Rick A Weideman, Danni McMahan, et al.
JACC. Advances|January 6, 2025
Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk ScoreSubhash Banerjee, Rick A Weideman, David A Jacob, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2020
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United StatesNicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, et al.
Pageof 2